Earth Science Tech Inc. (OTC: ETST) is positioning itself as a vertically integrated healthcare company through its subsidiaries RxCompoundStore, Mister Meds, and Peaks Curative, combining compounding pharmacy, telemedicine, clinical support, and fulfillment capabilities. This integrated model allows the company to serve independent clinics while also selling customized medications directly to consumers, creating diversified revenue streams across physical and digital healthcare operations.
In FY2026, ETST reported revenue of $35.7 million, up from $33.1 million in FY2025 and $11.95 million in FY2024. The company also reported positive operating cash flow and a stronger balance sheet, reducing total liabilities from $3.146 million to $1.928 million, increasing assets from $7.066 million to $8.969 million, and fully repaying its long-term debt. ETST expects operating cash flow to fund its FY2027 needs without additional dilutive financing, highlighting a strategy of pursuing growth through internally generated cash rather than debt or shareholder dilution.
The company's business model is designed to capture value across the healthcare continuum, from consultation to fulfillment. Its subsidiaries work in synergy to provide seamless patient care. RxCompoundStore offers compounding pharmacy services, Mister Meds provides telemedicine platforms, and Peaks Curative delivers clinical support and direct-to-patient fulfillment. This vertical integration enables ETST to address the needs of both healthcare providers and consumers directly.
For the Long Beach, California, area and surrounding region, ETST's growth and financial stability could signal broader opportunities in the healthcare sector. The company's focus on compounding pharmacy and telemedicine aligns with increasing demand for personalized medication and remote care services. As ETST continues to expand, it may contribute to local employment and innovation in digital health, while also providing a model for other healthcare businesses seeking to integrate services and improve margins.
The financial turnaround is notable given the company's revenue growth trajectory. From FY2024 to FY2026, revenue nearly tripled, demonstrating strong execution on its integrated strategy. The reduction in liabilities and full repayment of long-term debt further strengthens the company's balance sheet, providing flexibility for future investments. ETST's ability to generate positive operating cash flow suggests that its operations are not only growing but also becoming more efficient.
Investors and industry observers may view ETST's performance as a sign of resilience in the healthcare sector, particularly for companies that combine physical and digital services. The company's success in avoiding dilutive financing could appeal to shareholders concerned about value preservation. For more information, visit the full article and Earth Science Tech's website.
As the healthcare landscape evolves, ETST's vertically integrated platform may serve as a case study for other companies aiming to streamline operations and capture diverse revenue streams. The company's performance in FY2026 underscores the potential of combining compounding pharmacy, telemedicine, and direct fulfillment to drive sustainable growth.
